Title : Renoprotective mechanisms of sodium-glucose co-transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease.

Pub. Date : 2022 Feb

PMID : 34713897






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) have emerged as a promising class of antidiabetic drugs with cardioprotective and renoprotective effects in patients with type 2 diabetes (T2D). Glucose solute carrier family 5 member 2 Homo sapiens
2 The sodium-glucose co-transporters 1 and 2 (SGLT 1 and SGLT2) located in the renal proximal tubules are responsible for glucose reabsorption from the glomerular filtrate back into the systemic circulation. Glucose solute carrier family 5 member 2 Homo sapiens
3 Inhibition of SGLT2, which accounts for about 90% of the glucose reabsorption, leads to a significant reduction in blood glucose levels and a concomitant increase in the urinary excretion of glucose (glycosuria). Glucose solute carrier family 5 member 2 Homo sapiens
4 Inhibition of SGLT2, which accounts for about 90% of the glucose reabsorption, leads to a significant reduction in blood glucose levels and a concomitant increase in the urinary excretion of glucose (glycosuria). Glucose solute carrier family 5 member 2 Homo sapiens